In T1D, the autoimmune destruction of one’s pancreatic beta cells inhibits completely (or near completely) their ability to produce and secrete endogenous insulin, causing a lifelong reliance on exogenous insulin therapy for survival after diagnosis. The gene discussed is INS; the disease is type 1 diabetes mellitus.